WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'0101 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 9'0631 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 2'881  2'872  2'862  2'852  2'841  2'657  2'424  2'163 
Births 48  48  49  49  49  57  62  63 
Surviving infants 47  48  48  48  49  55  60  61 
Pop. less than 5 years 205  207  209  215  223  289  293  286 
Pop. less than 15 years 662  674  688  706  726  854  843  859 
Female 15-49 years 774  772  769  764  759  684  607  494 

Number of reported cases

(Click for retrospective incidence data for Jamaica)
Diphtheria
ChartChart
  13 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  3'651  36 
Mumps
ChartChart
  10 
Pertussis
ChartChart
  23  13 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Jamaica)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   78  96  99*  90  93  96  93  98  38 
DTP1 2009  98  MICS   78  97  88  90  92  95  87 
DTP3 2009  92  MICS   78  99  91  92  93  96  86  86  24 
DTP4          87  80  85 
IPV1          95  33 
HepB_BD         
HepB3 2009  92  MICS   78  98  91  92  93  96 
Hib3 2009  92  MICS   78  99  91  92  93  96 
JapEnc         
MCV1          95  91  92  94  93  88  74 
MCV2          85  83  72  71  76 
MenA         
PCV1          77  39  48  99* 
PCV2          49  38  45  76 
PCV3          37  35  34  70 
Pol3 2009  92  MICS   78  99  91  93  86  96  86  87  34 
Rota1         
RotaC         
RCV1          95  91  92  94  93 
TT2plus 2009  26  MICS   78  95  53  56  32  59  55 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Jamaica)
BCG
  96  99  90  93  95  94  98  38 
DTP1
  99  97  97  97  98  97  95  48 
DTP3
  99  91  92  93  96  93  86  24 
HepB3
  98  91  92  93  96 
HepB_BD
 
Hib3
  99  91  92  93  96 
IPV1
  95  33 
MCV1
  95  91  92  94  93  88  74 
MCV2
  85  83  72  71  76 
PCV3
 
Pol3
  99  91  93  86  96  95  87  34 
RCV1
  95  91  92  94  93  88 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 92
From 80 to 89% 8
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 weeks; 3, 6, 18 months; 4-6 years; Yes Pertussis contrindication
DTwP 18 months; 4-6 years; Yes
DTwPHibHepB 6 weeks; 3, 6 months; Yes
HepB_Adult 1st contact; +1, +6 months; health care workers and contacts to Hep B positive cases
HepB_Pediatric 6 weeks; 3, 6 months; Yes Children <1 year who are not eligible to receive the pentavalent vaccine with whole cell pertussis
HIB 6 weeks; 3, 6 months; Yes pertussis contrindication
HPV Yes from October 2017
Influenza_Adult Yes adults with chronic diseases and health care workers, pregnant women, and other risk groups
Influenza_Pediatric Yes Children >6 months chronic disease on PATH
IPV 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes 1st dose is routine and the other doses for immunocompromised
MMR 12, 18 months; Yes
OPV 3, 5-6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes Children with sickle cell disease and HIV infected
Td 4-6 years; Yes pregnant women and adults
YF 12 months; Yes travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  13  13  13  13 

System performance

Total Nº districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number 13  12  12  13  12  11  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  92  92  100  92  85  85 
Nº districts with measles (MCV1) coverage >=95% number 10 
% of districts with MCV1 coverage >=95% From 0 to 100% 77  31  31  54  69  15  31 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 99  94  99  100  99  97  99 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.